Company Data

CytoMed Therapeutics Limited

Ticker
GDTC
Current Price
$2.3068 -3.08%
Market Cap
$26.6M
Price Target
Refer to Report
Volume
7.6K
52wk Range
$1.2 - $4.0499
Advanced Market Data

Overview

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy